Humana Inc
HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 9/3040% above fair value
$410.41−4.09 (-0.99%)
Close on Nov 2, 2026Market cap $49.28BP/E 38.7Yield 0.86%
Humana Consolidated Operating Cost Ratio by Year
Consolidated Operating Cost Ratio — Adjusted (Non-GAAP %) (%)
Humana Consolidated Operating Cost Ratio: 11.5% in FY2025, up 0.2 pts from a year earlier.
Latest, FY2025
11.5%
Period ended Dec 31, 2025
Change on a year earlier
+0.2 pts
11.3% in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Operating cost ratio - Adjusted (non-GAAP) | 13.0 | % | 13.2 | % | 11.5 | % | 11.3 | %”
Source: HUM Form 8-K Statistical Supplement (2026-02-11) ↗
Reported in HUM SEC Filings (8-K Statistical Supplement / 10-K / DEF 14A).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated Operating Cost Ratio — Adjusted (Non-GAAP %) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.5% | +0.2 pts | HUM Form 8-K Statistical Supplement (2026-02-11) ↗ |
| FY2024 | Dec 31, 2024 | 11.3% | -0.4 pts | HUM Form 8-K Statistical Supplement (2026-02-11) ↗ |
| FY2023 | Dec 31, 2023 | 11.7% | -1.1 pts | HUM Form 8-K Statistical Supplement (2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 12.8% | +0.7 pts | HUM Form 8-K Statistical Supplement (2024-01-25) ↗ |
| FY2021 | Dec 31, 2021 | 12.1% | -1.2 pts | HUM Form 8-K Statistical Supplement (2023-02-01) ↗ |
| FY2020 | Dec 31, 2020 | 13.3% | – | HUM Form 8-K Statistical Supplement (2022-02-02) ↗ |
Cite this data
StockData. (2026). Humana Consolidated Operating Cost Ratio (%), annual FY2020–FY2025 [Data set]. Compiled from Humana SEC filings and investor materials. https://stockdatahq.com/stocks/hum/kpis/cons-op-cost-ratio-adj
See every metric in the Humana KPI table. Data updated Nov 2, 2026.